RenaSci has developed and validated a range of assays and in vivo models to assess the therapeutic potential of novel drugs to treat obesity. These include detailed assessments of food intake (energy intake), energy expenditure and body composition analysis to confirm that weight loss is a result of the specific loss of fat.



Get in touch to find out more.

Contact us

For more details or information on how we can support your project please complete the contact form.